Multiple molecular alterations in mouse lung tumors

✍ Scribed by Fabio C. Re; Giacomo Manenti; Maria G. Borrello; Mario P. Colombo; James H. Fisher; Marco A. Pierotti; Giuseppe Della Porta; Tommaso A. Dragani

• Book ID: 102945438
• Publisher: John Wiley and Sons
• Year: 1992
• Tongue: English
• Weight: 594 KB
• Volume: 5
• Category: Article
• ISSN: 0899-1987
• DOI: 10.1002/mc.2940050211

✦ Synopsis

Abstract

Twenty‐five mouse lung tumors induced by a single urethan treatment in female A/J, BALB/c, and (A/J × C3H/He)F1 (AC3) mice were analyzed for the presence of mutations at codon 61 of the Ki‐ras gene and for the expression of the surfactant protein A (SP‐A). retinoblastoma (Rb), growth arrest‐specific‐3 (gas‐3), p53, c‐myc, and thymidylate synthase (TS) genes. Ki‐ras codon 61 mutations were detected in 22 of 25 tumor samples without differences among strains. In comparison with normal lungs, all the tumors showed increased SP‐A mRNA levels, indicating their derivation from alveolar type II pneumocytes or Clara cells. Rb and gas‐3 transcripts were instead found in all tumors at about tenfold and about 20‐fold reduced levels, respectively. No apparent structural alterations or loss of heterozygosity at the Rb locus was detected in any tumors. The p53 mRNA was observed without variation in quantity or size in lung tumors and normal tissue. A threefold to fivefold c‐myc overexpression was observed, without amplification of the gene. TS expression was only slightly increased, indicating no great differences in cell proliferation between lung tumors and normal tissue. Our data suggest that the pathogenesis of urethan‐induced lung tumors in mice involves specific and recurrent molecular alterations (Ki‐ras mutations, decrease of Rb and gas‐3 expression, and increase of c‐myc expression) that could represent different steps in lung carcinogenesis. © 1992 Wiley‐List, Inc.